リジェネフロ
Kyoto, JP · 3 known investors
Rege Nephro develops regenerative medicine therapies for kidney disease, focusing on nephron progenitor cell research and differentiation from iPS cells. The company aims to commercialize treatments for patients with kidney disorders and reduce reliance on dialysis and transplantation.
BiotechHealthtechMedical Devices